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Abstract
The incidence of limb bone fracture and subsequent morbidity and mortality due to excessive bone loss is increasing in the
progressively ageing populations of both men and women. In contrast to bone loss in the weight-bearing limb, bone mass
in the protective skull vault is maintained. One explanation for this could be anatomically diverse bone matrix characteristics
generated by heterogeneous osteoblast populations. We have tested the hypothesis that adult bones demonstrate site-
specific characteristics, and report differences at the organ, cell and transcriptome levels. Limb bones contain greater
amounts of polysulphated glycosaminoglycan stained with Alcian Blue and have significantly higher osteocyte densities
than skull bone. Site-specific patterns persist in cultured adult bone-derived cells both phenotypically (proliferation rate,
response to estrogen and cell volumes), and at the level of specific gene expression (collagen triple helix repeat containing
1, reelin and ras-like and estrogen-regulated growth inhibitor). Based on genome-wide mRNA expression and cluster
analysis, we demonstrate that bones and cultured adult bone-derived cells segregate according to site of derivation. We
also find the differential expression of genes associated with embryological development (Skull: Zic, Dlx, Irx, Twist1 and
Cart1; Limb: Hox, Shox2, and Tbx genes) in both adult bones and isolated adult bone-derived cells. Together, these site-
specific differences support the view that, analogous to different muscle types (cardiac, smooth and skeletal), skull and limb
bones represent separate classes of bone. We assign these differences, not to mode of primary ossification, but to the
embryological cell lineage; the basis and implications of this division are discussed.
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Introduction
In weight-bearing bones, a mechanically-driven homeostatic
feedback mechanism is used to achieve a ‘target strain’ level and
ensures that bone strength is maintained to resist fracture [1,2].
This mechano-adaptive mechanism can fail, and when bone mass
no longer matches mechanical demands, fractures are likely to
ensue. Questions generally address ‘why is bone mass lost from weight-
bearing limb bones despite continued usage?’ However, in parietal bones
of the skull the levels of strain are low (low enough to induce
‘disuse’ bone loss in the limb) yet paradoxically, skull bones attain
mechanical competence and resist potentially catastrophic levels
of osteopenia despite this dramatic difference in the local
mechanical environment [3,4]. Therefore, it might be better to
instead frame the question in a different manner and ask ‘how is
bone mass and mechanical competence achieved in low weight-bearing skull
bones despite continued ‘disuse’?’ Addressing the latter question leads to
a conceptually novel approach to understand the attainment of
mechanical competence in limb bones.
Several lines of evidence have suggested persistent differences in
the adult bones derived from the distinct primary ossification
processes. In humans and rodents, the mineral density and
calcium concentration is greater in the skull than in the post
cranial skeleton [5–9]. Osteocytes of mouse skull vault calvarial
bones have a rounded appearance compared with the more
elongated osteocytes of long bone fibulae [10]. Matrix composition
differences have been described [11] and demineralised powder
from skull bone does not induce bone formation by an
endochondral ossification mode as limb bone derived powders
[12]. Mechanical strain (e) is the ratio of the change in length (new
length (L9) minus original length (L)) divided by L, is defined as:
(L9–L)/L and thus, has no units. A positive strain represents
stretching, whilst compression is represented by a negative figure.
Direct experimental measurements in a human showed that the
strain levels in the parietal bone of the skull are 10 fold lower
compared with the tibia [4]. We have previously demonstrated
peak surface strains on the rat parietal bone of only 30 me [3] –
and that such bones are not mechanically responsive [3,13]. If
limb bones, that normally experience habitual functional strains
ranging between 1800–3200 me [14], were subject to such low
mechanical strain levels, significant bone loss would ensue.
Intriguingly, parietal bones of the skull vault do not appear to
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be subject to such ‘disuse’ bone loss [15–17]. The skull bones are
also resistant to post-menopausal hormonal changes or glucocor-
ticoid treatment-induced osteoporosis. Clinically, autogenous bone
grafting using blocks of intramembranous bone resorb less than
bone derived from endochondral sites [18–20].
These differences may be a consequence of the site-specific
differences in osteoclast activities [21–23], however the observations
also imply that the mechanisms regulating site-specific osteoblast
behaviour/matrix production are autonomous. The basis of this
independence, and especially the intrinsic characteristics of skull
and limb osteoblasts, has not, to our knowledge, been fully assessed.
We suggest that cell lineage, where limbs develop from lateral plate
mesoderm and the skull from cranial neural crest [24], may in part
contribute to such autonomy. The existence of lineage based
differences in the skeleton is supported by specific developmental
defects that are restricted to different skeletal compartments.
Disruption of the TBX family of mesoderm transcription factors
affects limb development (TBX5; Holt-Oram syndrome, TBX3;
Ulnar-mammary syndrome [25,26]) whereas Cart1 knockout mice
are born without a cranium [27], Dlx52/2 mice are born with
abnormal osteogenesis of the skull vault and delayed cranial
ossification, whilst the limbs show no obvious defects [28].
We postulated that skull (S) and limb (L) bones of the adult, and
the bone-derived cells (Bdc) isolated from them (S-Bdc and L-Bdc)
would have distinct transcriptomes reflecting specific origins. We
have, therefore, investigated basal gene expression patterns by
genome-wide microarray analysis. The consequence of any such
transcriptome differences may be manifest as characteristic local
osteoblast behaviour; therefore, we have studied bone matrix
composition and the effect of ovariectomy on osteocyte number in
vivo. We have also compared the in vitro characteristics of isolated S-
Bdc and L-Bdc, testing whether they differ with respect to
proliferation rates and cell volume. We show site-specific differences
in the cellular and material composition of bone organs, and
patterns of basal gene expression in skull and limb bones and adult
bone-derived cells. In culture, the differential gene expression
continues to reflect their site of origin, and the phenotypes of S-Bdc
and L-Bdc differ. Surprisingly, we also note the persistent expression
of site-specific markers associated with development of the skeleton
in both bone organ and isolated adult bone-derived cells.
Results
mRNA expression in bone organs
1236 genes (approximately 4% of the genome) were found to be
significantly and, at least two-fold differentially expressed between
ulnar limb and parietal skull bone. Cluster analysis segregated the
two sites into distinct populations (Figure 1).
We selectively searched for those differentially expressed genes
previously associated with the ossification process, Wnt signalling,
developmental patterning and osteoporosis. Polymorphisms of a
number of genes differentially expressed in our rat bone array
have been associated with susceptibility to human osteoporosis
[29–31]: Opg (skull:limb, fold increase 3.1), Vdr (4.8), Pthr1 (2.9),
Calcr (4.6), Lrp5 (2.2), and Ctsk (2.7), Alox12 (0.2), Table 1.
Cathepsin K, is generally considered as a marker for osteoclasts.
Therefore, the increased expression detected in the skull samples
may reflect a difference in osteoclast numbers at this site. This
difference, however, is lost in the osteoblast cultures (see below).
The differential expression of transcription factors (Table 2)
between distinct anatomical bone locations may account for
the site-specific mineralization levels, underlie their differential
susceptibility to pathological osteopenic changes, and also be
central to specification.
Markers for homeobox genes associated with embryological
development and body patterning are expressed site specifically in
adult bones (Table 3. In addition, our preliminary data using adult
mice bones are also presented in this table, and demonstrates
positional identity marker expression, at least, appears to be
conserved between these two species).
In work published by Xing et al., in vivo mechanical loading
induced significant changes in the expression levels of genes in
loaded limbs compared with control (unloaded) limbs [32]. We
have compared their published set of mechanically responsive
genes with our set of basal, site-specific differentially expressed
genes. The common genes from these two data sets are presented
in Table 4. It is apparent that some of the genes whose expression
is stimulated by osteogenic mechanical loading are also constitu-
tively expressed more highly in skull bone.
mRNA expression in primary adult bone-derived cells
Even in attempts to generate monocultures, cultures of isolated
osteoblasts from bone tissues will contain other cell types. The cells
used in these experiments are from third collagenase digests of
adult bone and may thus contain osteoblasts along with osteocyte,
osteoclast, endothelial, neuronal and adipocyte cells. As a
precaution, genetic markers indicative of contamination with
another tissue type were assessed. Markers selective for osteoclast,
adipocyte, neurofilament, monocyte, muscle and endothelial cell
were expressed, if at all, at low levels in the cultures. There was no
significant difference in the expression of these markers between
the S-Bdc and L-Bdc cultures (data not shown). The level of gene
expression of osteocalcin was low.
249 genes were significantly and differentially expressed in
S-Bdc and L-Bdc. This represents approximately 1% of the
genome, and cluster analysis segregates these samples by their site
of origin (Figure 2A). Again, markers for regional development
Figure 1. Bones from functionally different skeletal sites
represent biologically distinct populations. Dendrogram gener-
ated by gene tree clustering analysis in GeneSpring 6.1 comparing basal
expression of all filtered genes in skull and limb bone organs. Colours
represent those genes (1236 of the genome) having expression levels
with at least a significant, two-fold difference.
doi:10.1371/journal.pone.0008358.g001
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and bone metabolism are differentially expressed site-specifically
(Figure 2A, B). The absolute level of expression of markers
associated with regional identity is low compared with bone
differentiation markers, but the differential expression between
sites is relatively large (3x–260x). Conversely, expression levels of
bone differentiation markers are high, but differential expression
differences are relatively small (3x–6x).
Expression of Hoxa cluster genes in S-Bdc and L-Bdc were
determined by qRT-PCR. Levels of all Hoxa genes are around
detection threshold in S-Bdc compared with consistently higher
levels of expression in L-Bdc. There was no significant difference
between in the expression of Hoxa2, whereas significance levels
were p,0.01 for all other comparisons (Figure 3).
To distinguish whether this distinct pattern of Hoxa expression is
seen in other endochondral bones, we compared Hoxa expression
in osteoblasts isolated from other limb and axial (rib) bones
(Figure 4). Compared with the appendicular bones, the relative
expression of genes in the Hoxa cluster were lower in the rib,
except for Hoxa2 and Hoxa5. Evidence for posterior prevalence in
the adult is apparent; Hoxa13 is not expressed in the femur samples
whilst Hoxa13 is expressed in tibial and ulnar bones which are the
more distal skeletal elements.
Table 5 presents validation of the gene array techniques with
qRT-PCR, and illustrates the close comparison of fold differences
between gene array and qRT-PCR in a range of significant and
differentially expressed transcription factors, receptors and matrix
proteins.
The difference in the number of differentially expressed genes in
bone (1236) and isolated cell (249) cultures may reflect the
populations that comprise the two models. Whilst we have
provided culture conditions that favour osteoblasts over other cell
types, we accept other cell types may be present. However, in the
bone organ we know there are more cell populations present
within the samples (for instance, osteocytes, adipocytes, endothe-
lial, neuronal-like hematopoietic cells). Notwithstanding, in either
case, cluster analysis segregates skull and limb bone and isolated
osteoblasts into separate populations.
Skull and limb bone matrix phenotype
Clearly the gross anatomy of skull and limb bones is distinct, but
so too is the finer structure (Figure 5A and B). The concentration of
polysulphated glycosaminoglycans in the osteoblast-derived bone
matrix is significantly greater (36%) in limb bone compared with skull
bone (Figure 5C, D and E). The number of osteocytes per unit volume
Table 1. Differentially expressed genes in skull and limb bone associated with developmental patterning, Wnt signalling,
osteoporosis and ossification.
High expression in skull Gene Symbol S:L ratio Gene Symbol S:L ratio High expression in limb Gene Symbol S:L ratio
Sfrp2 13.51 Alcam 2.58 Btg2 0.49
Cart1 10.76 Eln 2.57 Grpca 0.49
Sost 5.36 Prelp 2.54 Svil 0.48
Amelx 5.12 Twist1 2.51 Lect2 0.43
Vdr 4.81 Sema5a 2.49 Best5 0.38
Calcr 4.66 Bmpr2 2.48 Comp 0.38
Ambn 4.23 Sp7 2.42 Mmp8 0.29
Wif1 4.17 Ank 2.37 Pdlim7 0.24
Gpnmb 3.81 Lrp4 2.35 Bmp5 0.22
Cd276 3.74 Mmp13 2.32 Ctnnb1 0.20
Igfbp5 3.68 Nab2 2.26 Wnt16 0.06
Tcf7 3.51 Dlx5 2.22 Hoxa5 0.05
Bmp3 3.43 Ptprv 2.20 Shox2 0.05
Bmp6 3.29 Enpp1 2.19 Cacna1s 0.04
Acp5 3.28 Tpp1 2.19 Csrp3 0.04
Nog 3.24 Cdh15 2.17
Frzb 3.14 Dlx3 2.16
Cyp26b1 3.04 Lrp5 2.15
Tnfrsf11b 2.93 Ptn 2.13
Calca 2.92 Cpz 2.09
Pthr1 2.91 Ibsp 2.09
Csf1r 2.89 Omd 2.08
Cthrc1 2.83 Fgfr1 2.06
Csf1 2.82 Tcf3 2.04
Plau 2.81 Mitf 2.01
Mmp9 2.78 Igf2bp2 2.00
Ctsk 2.70
S:L ratio = Skull:Limb ratio.
doi:10.1371/journal.pone.0008358.t001
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of skull and limb bone differ significantly (40% greater in the limb,
p,0.001, n=5matched pairs). A change in bone cellular composition
was measured after 7 months of growth following ovariectomy.
Osteoblast incorporation as osteocytes into bone matrix was reduced
in limb bone, but remained unaltered in the skull vault (Figure 5F).
S-Bdc and L-Bdc phenotype
Adult bone-derived cells in culture were assessed for differences
in proliferation rates and cell size. Direct cell measurements
showed that mean cell volume and diameter measurements were
greater (26%, p,0.02 and 8.5%, p,0.02 respectively, n = 5
matched pairs) for S-Bdc compared with L-Bdc (Table 6). Cells
were plated at identical starting densities and showed significant
differences in number (as judged by MTS assay) after 3 days in
culture (S-Bdc . L-Bdc, p,0.004, n = 5 matched pairs), L-Bdc
were still proliferating at day 4 (Figure 6). The effects of
osteotrophic agents on alkaline phosphatase (ALP) activity were
assessed in both S-Bdc and L-Bdc. Data was normalised to DNA
content. Estrogen (1028 M) decreased ALP activity in S-Bdc, but
increased activity in L-Bdc (Figure 7). The number of mineralized
nodule generation in culture was low (data not shown), and
probably reflects the low levels of osteocalcin expression.
Discussion
Our analysis reveals that the matrices of these functionally
distinct bones show measurable differences in composition.
Glycosaminoglycan (Gag) concentrations are higher in limb bone.
Osteocyte density in the limb bone was decreased in OVX
animals, which is consistent with OVX-induced decreases in other
non-cranial skeletal sites [33]. However, the osteocyte density in
skull bone was unaffected during growth in an ovarian estrogen-
depleted animal. This is consistent with differential responses of
regional skull and limb osteoblasts and the pattern of bone loss
induced by menopausal hormonal changes. However, we can not
preclude that any decrease is partly in response to ageing [34].
Although we do not have direct evidence that the local patterns
of gene expression in individual bones of the skeleton would
determine site-specific characteristics [35] it is a distinct possibility.
Differential expression of genes linked to osteoporosis in skull and
limb bones is a powerful argument to mis-express these genes in
limb bone in future studies. However, those genes differentially
expressed in both bone organ and osteoblast cultures are more
likely to establish these genes as potential therapeutic targets. Two
such genes are detailed here, namely collagen triple helix repeat
containing 1, (cthrc1) and reelin (reln).
Table 2. Differentially expressed transcription factors in skull and limb bone.
Gene Symbol S:L ratio Gene Symbol S:L ratio Gene Symbol S:L ratio Gene Symbol S:L ratio
Meis2 31.07 Nfib 2.52 Kpna1 0.50 Sox6 0.32
Nr2f1 11.02 Sox17 2.51 Solt 0.50 Tal1 0.32
Cart1 10.76 Twist1 2.51 Btg2 0.49 Gfi1b 0.31
Zic3 10.15 Lztr2 2.49 Rab8b 0.49 Trib3 0.31
Rfx4 8.56 Rai14 2.47 Chd4 0.48 Hoxc5 0.30
Zic4 8.13 Maf 2.40 E2f8 0.48 Gata1 0.29
RGD1311558 4.98 Tbx2 2.39 Gata3 0.48 Klf1 0.28
Wnk4 4.84 Satb2 2.35 Mafg 0.47 Padi4 0.28
Vdr 4.81 Kcnh2 2.27 Mafk 0.47 Ppp1r12b 0.27
Zic1 4.26 Nab2 2.26 Trak2 0.47 Trim29 0.27
Pax8 4.06 RGD1565031 2.25 Abtb1 0.46 Unr 0.27
Fbxl22 3.73 Dlx5 2.22 Cebpe 0.45 Ankrd1 0.26
Tcf7 3.51 LOC685277 2.20 Klf5 0.45 Hand2 0.26
Hdac10 3.40 Nr2f2 2.18 Tcfdp2 0.45 Fhdc1 0.25
Cdkn2a 3.31 Dlx3 2.16 Ybx2 0.45 Hoxb8 0.25
Prdm1 3.04 Mxd4 2.15 Creg 0.44 Thrsp 0.23
C2ta 2.92 Nfatc4 2.13 Tbx15 0.44 Bach1 0.22
Creb3l1 2.92 Rai14 2.12 Cited4 0.42 Dmrt2 0.21
Jundp2 2.89 Zfhx3 2.11 Sec14l2 0.42 Smyd1 0.21
Zfhx4 2.78 RGD1305899 2.05 Mlf1ip 0.41 Ctnnb1 0.20
Flywch1 2.68 Tcf3 2.04 R1b 0.41 Hoxa7 0.19
Pde8a 2.68 Epas1 2.03 Zfp278 0.40 RGD1561431 0.15
Fos 2.67 Hes1 2.01 Hipk3 0.37 RGD1566402 0.12
Maged1 2.63 Mitf 2.01 Asb1 0.34 Shox2 0.11
Armc9 2.57 Zfp98 2.01 Centg3 0.34 Tbx5 0.08
Supt3h 2.56 Nfe2 0.34 Hoxa10 0.06
Npas3 2.54 Zfp207 0.34 Hoxa5 0.05
Uncx4.1 2.54 Phox2a 0.32
S:L ratio = Skull:Limb ratio.
doi:10.1371/journal.pone.0008358.t002
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cthrc1 has been implicated in increased osteoblast proliferation
and higher bone mass; in isolated osteoblasts from cthrc1-null mice,
alkaline phosphatase, collagen type 1a1 and osteocalcin expression
levels were reduced [36]. Further, cthrc1 impacts on responsive-
ness to TGF-b and subsequently TGF-b target genes including
collagens type I, a1 and a2 in PAC1 cells [37]. The canonical Wnt
pathway is involved in the regulation of limb bone mass [38] but
not development of the skull [39] and cthrc1 has been shown to
suppress the canonical pathway and activate the planar cell
polarity (PCP) pathway [40]. cthrc1 expression was significantly
greater in bone organ (2.8) and adult bone-derived cell (3.73)
samples derived from the skull (2.83 and 3.73 times, respectively),
suggesting Wnt/PCP-based signalling maybe more important in
osteoblasts in the skull. We are unable, however, to detect any
differential expression in the potential downstream osteotrophic
targets in these adults.
Differential expression of several neurogenic markers was
identified in bone samples. In particular, there was elevated
expression of reln in limb bone (2–3 fold) and L-Bdc (7.7 fold,
Table 5). Reln expression has recently been associated with
abnormal bone remodelling of the otic capsule in the pathogenesis
of otosclerosis [41]. The extracellular protein reelin is associated
with axonal guidance and the basis of learning and memory via
synaptic plasticity [42]. The significance of the neuronal-like
appearance of the osteocyte network has been previously noted
[43] and osteocytes have been proposed as mechano-sensors
[43,44] that communicate to maintain target strain with brain-like
glutamate-based mechanisms [45–47]. Hypermethylation of the
reln promoter is often seen during ageing and is associated with its
reduced expression [48]. In the brain, reduced reln expression or
reelin signalling activity is implicated in the generation of
Alzheimer’s disease [42]. It is tempting to speculate a role for
osteocytic reelin [49] in the loss of mechanically-regulated limb
bone remodelling and target strain maintenance in the aged.
Measurement of the osteogenic response to applied mechanical
loading of the reln knockout, reeler, mouse [50] would test the
importance of reelin in limb bone biology. Interestingly, reln
expression in skull bone and S-Bdc is significantly lower compared
with limb bone and L-Bdc. This is consistent with skull bones
possessing a distinct pathway independent of the mechano-
adaptive system of the limb.
A third differentially expressed gene, with increased expression
in skull bone (skull:limb ratio 2.9) and S-Bdc (8.3), is rerg - a ras-like
and estrogen-regulated growth inhibitor [51]. In manipulated
HEK293 cells, rerg is a target gene of the estrogen receptor-b [52],
there are as yet, however, no defined roles for rerg in bone cell
biology. Whether the differential effects of estrogen on ALP
activity (Figure 7) are modified by rerg has not been assessed.
Table 3. Differentially expressed genes in rat and mouse
bone associated with embryological development and body
patterning.
Skull:Limb
ratio GENE RAT MOUSE RAT MOUSE
Hoxa3 2.33 Skull only Hoxa2 Phox2a
Hoxa5 0.05 0.12 Hoxd3 Tbx18
Hoxa7 0.19 0.17 Irx1 Tbx19
Hoxa10 0.06 0.14 Irx2
Hoxa11 0.15 Irx4
Hoxa11s 0.04 Twist2
Hoxb7 0.41 Msx2
Hoxb8 0.25 Tbx1
Hoxc5 0.30 Tbx3
Hoxc6 0.30 Runx1
Hoxd8 0.27 Limb only Hoxc9 Tcfe3
Cart1 10.76 4.55/3.65 Tcfe3
Dlx1 2.21/0.31
Dlx3 2.16 2.38
Dlx5 2.22 2.60
Msx1 3.19/0.44
Msx2 2.96
Phox2a 0.31
Shox2 0.08/0.14 0.06/0.18
Tbx2 2.36/2.4 2.75
Tbx3 0.32
Tbx5 0.07
Tbx14 0.06
Tbx15 0.44 0.36
Tcf3 2.04 2.07
Tcf4 0.20
Tcf7 3.51
Tcfcp212 2.91
Twist1 2.31/2.70 11.49
Twist2 0.34
Zic1 4.26 25.80
Zic2 12.53
Zic3 8.66 24/4.79
Zic4 8.13 5.20/4.34
Zic5 9.32/6.65
Some genes are represented with more than one probe set on the array,
therefore some genes have two values.
doi:10.1371/journal.pone.0008358.t003
Table 4. Genes induced by loading in the limb (*) and
differentially expressed basally between skull and limb bone.
(*) Xing et al. JCB 96:1049–1060 (2005).
Gene symbol Skull v Limb
Ankrd1 0.26
Emp1 2.15
Ephb2 3.49
Fkbp9 2.19
Fkbp11 2.12
Lepre1 2.55
Maged1 2.63
Mkrn1 0.33
Ogn 2.01
PCDH19 2.33
Ptn 2.13
Rcn 2.74
Rhced 0.32
Serpinh1 2.09
Timp1 3.04
doi:10.1371/journal.pone.0008358.t004
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Positional identity along the anterior-posterior body and
proximal-distal axis of the limbs relies on the pattern of homeobox
gene expression. Hox genes act in a hierarchical manner based on
‘posterior prevalence’ whereby the most posterior expressed Hox
gene determines positional identity [53,54]. This mode of
patterning is reinforced by Hox gene/microRNA clusters that
promote suppression of the anterior characteristics [54]. Expres-
sion of Hox genes could therefore be part of the mechanism that
directs osteoblasts to function appropriately for their skeletal
location [55].
To confirm that regional gene expression profiles are an
inherent property, and not dependent upon the local mechanical
environments, we investigated Hoxa gene expression profiles in
adult bone-derived cells in a range of long bones and from the rib.
Differential Hoxa expression profiles (Hoxa2, Hoxa5, Hoxa7 and
Hoxa10) are clearly evident in these endochondral/mesoderm
bones. Investigations have not yet disclosed whether such regional
gene expression differences underscore the differential responses to
systemic anti-osteoporotic bisphosphonate treatment [56]. Con-
cordant with posterior prevalence, Hoxa13 is present only in the
ulna and femur samples. Our observations agree with studies
showing that cultured human skin fibroblasts express a specific
HOX gene profile depending on the region of the body from
Figure 2. Genotypic differences between 5 matched pairs of skull and limb adult bone-derived cells. (A) Dendrogram signifying
populations are distinct in isolated S-Bdc and L-Bdc. (B) Heat map for markers for regional development: cultured S-Bdc – (S1–S5) preferentially
express genes associated with the craniofacial development of neural crest derived cells (red), whilst genes for limb development and patterning are
preferentially expressed by L-Bdc (L1–L5). Differential expression of bone-associated markers are also depicted; Alcam, activated leukocyte cell
adhesion molecule; Sfrp2, secreted frizzled-related protein 2; Apo-E, apolipoprotein E; Smoc2, SPARC related modular calcium binding 2; Spp1,
osteopontin; Fst, follistatin.
doi:10.1371/journal.pone.0008358.g002
Figure 3. Site-specific Hoxa cluster gene expression of cultured
adult bone-derived cells. Isolated osteoblasts derived from the skull
and limb of adult rats maintain a specific patterning of Hoxa gene
expression in culture.
doi:10.1371/journal.pone.0008358.g003
Figure 4. Site-specific Hoxa cluster gene expression profiles of
cultured adult bone-derived cells. Continued expression of
developmental patterning Hoxa genes demonstrate posterior preva-
lence in adult limbs; the more distal the skeletal element, the greater
the Hoxa number expression. For instance, Hoxa13 is expressed in the
more distal ulnar and tibial bones, but not in the more proximal femur.
doi:10.1371/journal.pone.0008358.g004
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where they are derived [57,58].
Although HOXA10 has been shown to regulate the expression of
RUNX2, ALP and osteocalcin [59], attributing a direct function to
the differential expression of Hoxa genes is difficult; site-specific cell
behaviour and local Hox gene expression profiles may simply be
correlated. However, in the adult, intramembranous-derived
mandibular periosteal cells (Hoxa11 negative) can fill wound defects
drilled into jaw and tibial limb bones. In contrast, periosteal cells
from the endochondral-derived tibia (Hoxa11 positive) fail to repair
the defect in the jaw; the transplanted cells differentiate into
chondroblasts rather than osteoblasts [60]. These experiments
suggest appropriate (source-dependent) function is correlated with
Hoxa11 expression. Phenotypic stability of osteoblasts is required
for the replacement of the appropriate bone tissue following
trauma and the remodelling process and increased expression of
Hox genes have been described at fracture sites [61,62]. Our data
suggests that phenotypic stability is maintained in osteoblasts but
that the appropriate site-specific behaviour may be more complex
than being simply positive or negative for expression of Hoxa11.
The persistence of homeobox gene expression profiles in the
adult mirror positional specification during embryogenesis and
suggests that cells maintain a ‘memory’ of their origin and/or body
positioning – an ‘epigenetic postcode’. These observations suggest
a basis by which autonomous regulation of osteoblast behaviour at
different sites and could explain in part how systemic hormonal
changes differentially affect the skeleton. These findings support
our contention that skull and limb bones form and are maintained
by distinct cell (osteoblast) populations. Whether there is any
correlation between the site-specific differences in osteoclasts
[21,22] and their homeobox expression profiles has yet to be
investigated.
There is still controversy regarding the embryonic lineage of the
parietal bone – whether it is mesoderm or cranial neural crest.
Grafting and fate mapping experiments show distinct lineages
compared with the use of Wnt-cre lineage tracing experiments. A
report by Yoshida, clearly shows the lack of neural crest cell
marker, X-gal staining in the parietal bones of Wnt1-cre/R26R
mice [63]. This may reflect the discontinuity of Wnt1 expression
along the neural tube, which shows a distinct gap in expression
around the hindbrain/midbrain junction [64]. This gap in
expression is approximately where neural crest that could
contribute to the parietal bone would be expected to arise.
Therefore it seems possible that at least some of the cranial neural
crest may remain unlabelled which and could account for the lack
of X-gal staining between the interparietal and frontal bones.
Cart1 expression in skull bone is surprising since cart1 is
predominately expressed in the chondrocyte lineage (Table 2).
However, cart1 is known to be essential for normal skull bone
development, null mice develop with normal limbs and trunk, but
the interpatietal and majority of the parietal and frontal bones are
absent [65]. It appears that during skull bone development a
unique cell type, the ‘chondrocyte-like osteoblast’ is present [66].
Whether cart1 is expressed by chondrocyte-like osteoblasts, and
whether this determines the nature and characteristics of skull
bone matrix has yet to be determined.
It has not been established whether the neural crest contribution
to bone tissues has any clinical relevance – however, the clavicle
may provide some useful insights to the development of skeletal
disorders. Unusually, this bone develops by both intramembra-
nous ossification (laterally) and endochondral ossification (medial-
ly) [67], and studies have demonstrated that only the medial aspect
contains cells derived from the cranial neural crest [68]. The
lateral aspect of the clavicle is prone to osteoporosis and is
consistent with other bones containing a neural crest component
(skull vault) being resistant to osteoporosis.
In conclusion, this study shows that genes associated with bone
mass and mineral density are differentially expressed in function-
ally distinct skeletal sites. Our observations also demonstrate
developmental gene expression-based ‘‘positional identity’’ in the
adult skeleton. If positional identity is significant for bone then
more favourable clinical outcomes would be expected with site
matching of bone source to recipient site in grafts and tissue
engineering/regeneration protocols. It may also be possible to
exploit differential positional identity markers to develop site-
directed pharmacological treatments. We propose that osteoblasts,
and the matrix they produce, differ according to their location and
that these differences are established, at least in part, by the
developmental origin of the cells that contribute to the site-specific
osteoblast lineage.
Materials and Methods
Ethics statement
All animal procedures were carried out in accordance with the
UK Home Office Scientific Procedures Act (1986). All animals
were purchased from Charles Rivers, housed, and fed ad libitum in
accordance with local Queen Mary University of London, School
of Medicine and Dentistry rules.
Animals
Male rats were housed until they reached weights that matched
those used in previous mechanical loading experiments [3].
Females were ovariectomised pre-pubertal (by the supplier) and
maintained until 7 months of age prior to assessment of osteocyte
number. The pilot studies used ten male skeletally mature Black
CD57 (24–26 grams) mice divided into two groups to test for the
feasibility of gene array in bone organs.
Adult bone-derived cell isolation and culture
Five male CD rats (100–110 grams) were rendered unconscious
with CO2 and killed by cervical dislocation. Skull and the cortex of
Table 5. Validation of gene array with qRT-PCR (Skull/Limb
ratio).
Sample Method Gene Array qRT-PCR
Bone organ Affymetrix CyclinD 3.92 2.97
Shox2 0.08 0.09
Ibsp 2.03 4.61
Cdh1 0.40 0.32
Lepre1 2.53 2.29
Cnr2 0.42 0.19
Cells Illumina Hoxa7 0.02 0.04
Irx5 16.10 6.95
Msx2 13.10 11.40
Reln 0.01 0.12
Spp1 0.30 0.08
Alpl 1.28 3.18
Expi 0.21 0.13
Bglap2 1.16 1.05
Tbx3 0.13 0.41
Tgfbi 0.20 0.11
doi:10.1371/journal.pone.0008358.t005
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ulnar bones were dissected and cleared of attendant soft tissues,
epiphyses and marrow. Individual samples were minced and bone
cells isolated by enzymatic digestion. Third digest cell populations
were used in the experiments. 5 matched pairs of adult bone-
derived cultures were thus isolated. Cells were cultured in aMEM
(Gibco), 10% newborn calf serum (First Link), 1x penicillin/
streptomycin and 1x fungizone) at 37uC, in a 5% CO2
atmosphere. Cells were fed every 2 days. Following passage,
osteoblast numbers, cell volumes and size were determined using a
CASYH (Model TTC) Cell counter and analyzer system. For
proliferation assessment, matched pairs were grown in a series of
6-well plates. Plates were removed from the experiment on a daily
basis and proliferation assessed using the PromegaH CellTiter 96
Aqueous Non-radioactive Cell proliferation assay system. The
MTS reaction product, formazan, was measured using a BMG
Labtech FLUOstar OPTIMA plate reader at 490 nm. To assess
ALP activity cells were washed in PBS and incubated with
12.5 mg p-nitro-phenylphosphate per ml of Sigma alkaline buffer
No. 221 at 37uC for 20 minutes. The reaction was stopped using
0.5 M NaOH solution and the yellow reaction product read on a
Figure 5. Phenotypic differences between skull and limb bone. Low power photomicrographs of (A) skull and (B) limb stained with Toluidine
blue for histology and higher power (C) skull and (D) limb bone stained with Alcian Blue 8GX. Regions of acellular bone matrix were masked in the
microdensitometer and measured. This ensured that the heavily stained osteocytes did not interfere with the readings. (E) Quantitative assessment
by microdensitometry of polysulphated glycosaminoglycan levels in bone matrix stained with Alcian Blue 8GX. (F) Ovariectomy alters osteoblast
incorporation into bone matrix as osteocytes in limb bone, but not skull bone, during growth.
doi:10.1371/journal.pone.0008358.g005
Table 6. Physical characteristics of S-Bdc and L-Bdc.
Parameter p-value Site Mean Std. Dev.
Diameter (mm) ,0.02 S-Bdc 19.49 0.55
L-Bdc 17.96 0.77
Volume (fl) ,0.02 S-Bdc 4692 375
L-Bdc 3719 473
doi:10.1371/journal.pone.0008358.t006
Site-Specific Bone Identity
PLoS ONE | www.plosone.org 8 December 2009 | Volume 4 | Issue 12 | e8358
plate reader at 405 nm. DNA content was assessed according
to methods determined by Rago [69]. Water-soluble 17b-estadiol
(E4389, estrogen), Prostaglandin E2 (P5640) and sodium pyro-
phosphate (P8010) were obtained from Sigma.
RNA extraction
Total RNA from skull and limb bones cleared of attendant soft
tissues and epiphyses or sutures was extracted from five groups of
four male CD rats (100–110 grams) using an RNeasy Fibrous
Tissue Mini Kit (Qiagen) as per protocol. For isolated S-Bdc and
L-Bdc, RNA was extracted from near confluent third passage cells
collected from the ten populations using the RNeasy Mini Kit
(Qiagen) as per protocol. RNA was extracted from osteoblasts
isolated from other long bones using the RNeasy Mini Kit from
first passage near confluent cultures.
Microarray analysis
The Affymetrix Mouse Genome 430 2.0 GeneChip and Rat
Genome 230 2.0 GeneChip were used to detail basal gene
expression profiles in the bone organ samples. Biotinylated targets
suitable for hybridization to the GeneChip probe arrays were
prepared from the RNA samples as per ‘One-Cycle Target
Labeling’ protocol (Affymetrix). Briefly, double-stranded cDNA
was synthesised from total RNA followed by in vitro transcription
reaction to produce biotin-labelled cRNA from the cDNA. The
cRNA was then fragmented prior to hybridization to the
GeneChip arrays. Analysis of data was performed using Gene-
Spring 6.1 (Silicon Genetics, Redwood City, USA) software. The
‘per chip’ and ‘per gene’ normalization procedures, as recom-
mended, were used. Statistically significant (ANOVA, p,0.05,
Benjamini and Hochberg false discovery rate) gene lists repre-
senting differentially expressed genes, and expression tree were
generated. The Illumina RatRef-12 Expression BeadChip was
used to detail basal gene expression profiles in the primary
cultured skull vault and ulnar osteoblasts. BeadStudio software was
used to analysis the data. A ‘Diff score’ of ,65 and .65 for gene
expression for 5 matched pairs are considered as significantly
different (p,0.05).
Gene array data is available on the NCBI Gene expression
omnibus, accession number: GSE12966.
qRT-PCR analysis
Gene array data was validated by qRT-PCR using Taqman
Assay-On-Demand oligonucleotides for the following genes
(Table 6). cDNA was prepared from 1 mg total RNA isolated
from each the 10 bones or primary cell lines using oligo dT
primers (Promega) and Promega reagents. The reaction conditions
were 70uC for 5 mins (denaturation), 60 mins 40uC for 60 mins
(extension), 70uC for 15 mins (inactivation), and then stored at
220uC. Each TaqMan assay was run in four replicates for each
RNA sample. 50 ng total cDNA (as total input RNA) in a 10 ml
final volume was used for each replicate assay. Assays were run
with 2xAbsolute qPCR ROX Master Mix (Abgene) on Applied
Biosystems 7900 Fast Real-Time PCR System using universal
cycling conditions (10 min at 95uC; 15 s at 95uC, 1 min 60uC, 60
cycles). The assays and samples were analyzed on 384 well plates.
Data normalization: in qRT-PCR an endogenous control gene is
used to normalize data and control for variability between samples
as well as plate, instrument and pipetting differences. Eif4a2 and
ATP5b were chosen as the reference genes because their CT values
showed the least variation across the samples (data not shown).
Each replicate CT was normalized to the average CT of Eif4a2 and
ATP5b on a per plate basis by subtracting the average CT of
Eif4a2 and ATP5b from each replicate to give the DCT which is
equivalent to the log2 difference between endogenous control and
target gene. When TaqMan gene expression assays are run on a
7900HT system in a 10 ml reaction volume, a raw CT value of 34
represents approximately ten transcript molecules (assuming 100%
amplification efficiency). At a copy number less than five,
stochastic effects dominate and data generated are less reliable.
Thus, a raw CT of 35 was set as the limit of detection in this study:
individual replicates which gave CT values .35 were considered
not detected. A CT .32 and ,35 (,5–40 transcript molecules)
was considered a low expressing gene. Differential expression of
selected genes in both gene arrays and qRT-PCR are presented in
Table 6.
Histological preparations
Decalcified bone sections (10 mm) were cut on a microtome
housed in a cryostat at 225uC (Bright’s) and flash dried onto glass
slides. Sections were stained overnight in 0.05% alcian blue 8GX
solution in 0.025 M acetate buffer (Sigma), containing 0.025 M
MgCl2 (Sigma) at a final pH of 5.8. A Vickers M85A scanning and
integrating microdensitometer was used to quantify the intensity of
Alcian Blue staining [70]. Osteocyte density was determined in
similarly prepared sections. 10 images of equal and known area of
Figure 6. Adult bone-derived cell proliferation. Assessment of
cell proliferation using MTS. Bone-derived cell populations from the
skull proliferates more rapidly than limb bone derived cells.
doi:10.1371/journal.pone.0008358.g006
Figure 7. Effect of osteotrophic agents on ALP activity of adult
bone-derived cells. Isolated adult bone-derived cells were seeded at
equal densities and treated with either b-estrogen (1028 M), Prosta-
glandin E2 (10
26 M) or inorganic pyrophosphate (0.5 mM) for four days.
Data is presented as percent differences from control. Estrogen
differentially regulates normalised ALP activity in S-Bdc and L-Bdc.
doi:10.1371/journal.pone.0008358.g007
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bone per section were captured (Olympus BHS microscope linked
to a Kontron image analysis system). Osteocyte number was
counted in two sections per bone and presented as number per
area.
Statistics
Data is presented as means and significance tested using paired
t-test, unless otherwise stated and p,0.05 was considered
significant.
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